Skip to content

Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03867578
Enrollment
26
Registered
2019-03-08
Start date
2018-10-10
Completion date
2022-07-20
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mesothelioma, Peritoneal Mesothelioma

Brief summary

For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these cancers. Researchers will use new MRI and ultrasound techniques to see if it can find evidence of cancer that has spread to the lining of the abdomen, and right now these new techniques are only used for research.

Interventions

DIAGNOSTIC_TESTHR-MRI

The first 5 patients will undergo HR-MRI scans using different sequence parameters. Results in these patients will then be assessed along with standard CT Imaging to determine which sequences appear to best identify peritoneal disease. The optimal HR-MRI sequences will then be used for the next 19 patients in the Testing phase to formally define their performance compared to standard imaging.

DIAGNOSTIC_TESTStandard CT Imaging

Standard CT scans will be performed for preoperative imaging in all patients.

DIAGNOSTIC_TESTUltrasound

Ultrasound Elastography will be performed using an FDA-Approved diagnostic GE ultrasound scanner

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years old or older 2. Biopsy-proven MPM 3. Surgery for PM planned at UCM within 60 days 4. Able to tolerate CT, MRI, US scans, and surgery 5. Able to provide written informed consent 6. For women of child bearing age, ability and willingness to use appropriate contraceptive methods before imaging and for a period of 365 days thereafter.

Exclusion criteria

1. Pregnancy / Breastfeeding 2. Allergy or intolerance to iodinated or gadolinum contrast dyes 3. Contraindications to CT or MRI imaging including chronic kidney disease with GFR \<60mL/min/1.73m2 4. Bioimplants unsuitable for MRI imaging (activated by mechanical, electronic, radiofrequency, or magnetic means), such as cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps 5. Permanent tattoos or eyeliner with magnetic dyes 6. Subjects with shrapnel or metal fragments lodged in the body 7. Anxiety, claustrophobia, or any medical condition that would preclude lying still in an MRI scanner for 1-1.5 hours 8. Cardiac, circulatory, or perspiration problems leading to impaired thermoregulation 9. Respiratory or cardiac impairment limiting the ability to lie flat 10. Inability to breath-hold for MRI acquisition 11. Vascular or aneurysm clips or any other surgical implant that is not MRI-compatible 12. Any other ferromagnetic bioimplant that would be damaged by MRI 13. Mental, cognitive, or mental health impairments that preclude the subject from providing informed consent or adhering to the treatment protocol 14. Subjects unable to adhere to the protocol or communicate effectively with researchers 15. Imprisoned subjects 16. Subjects with history of prior CRS/HIPEC or other peritonectomy surgery that might alter characteristics of the peritoneum

Design outcomes

Primary

MeasureTime frameDescription
Higher Sensitivity for detection using New High Resolution Contrast Enhanced MRI Imaging Sequences compared to standard MRI60 DaysNew HR-MRI sequences will demonstrate greater sensitivity than standard MRI for detecting peritoneal metastases.
Higher sensitivity for detection of peritoneal metastatic disease using Ultrasound Elastography compared to standard MRI60 DaysUltrasound Elastography will demonstrate greater sensitivity than standard MRI for detecting peritoneal metastases.

Secondary

MeasureTime frameDescription
The performance of diffusion-weighted MRI in detecting peritoneal disease in patients with malignant peritoneal mesothelioma60 daysUse diffusion-weighted MRI in detecting the per-region sensitivity in patients with MPM
Test high-definition small-voxel MRI imaging sequences for detection of peritoneal disease in MPM60 daysTo test HR-MRI sequences for detection of peritoneal disease in MPM focusing on the right hemidiaphragmatic and pelvic spaces
Perform Ultrasound Elastography in peritoneal mesothelioma to determine optimal strain ratios60 daysUltrasound Elastography to determine optimal strain ratios to maximize sensitivity in PM patients
Perform Ultrasound Elastography in peritoneal mesothelioma to determine elasticity scores60 daysUltrasound Elastography to determine elasticity scores to maximize sensitivity in PM patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026